A Oneindia Venture
Get Updates
Get notified about market trends, financial advice, and investment tips!
Click it and Unblock the Notifications
UTI Healthcare Fund - Direct Plan
Regular
Direct
3 Year Absolute Returns
107.94% ↑
NAV (₹) on 07 May 2026
344.60
1 Day NAV Change
0.37%
Risk Level
Very High Risk
Rating
-
UTI Healthcare Fund - Direct Plan is a Equity mutual fund categorized under Sector, offered by UTI Asset Management Co. Ltd.. Launched on 01 Jan 2013, investors can start with a minimum SIP of ₹100 or ... Read more
NAV History
Fund Details
Min. SIP Amount
₹500
Inception Date
01 Jan 2013
Min. Lumpsum Amount
₹ 5,000
Fund Age
13 Yrs
AUM
₹ 1,055.53 Cr.
Benchmark
BSE Healthcare Total Return
Expense Ratio
1.30%
Scheme Type
Open Ended
Exit Load
1%
Returns Calculator
Investment amount per month
₹1,000
Over the past
Would have become
On total investment of
*Calculation based on past performance of this fund.
Asset Allocation
AUM
₹ 1,055.53 Cr
Equity
294.22%
Debt
0.02%
Other Assets & Liabilities
5.77%
Sector Holdings
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 74.68% |
| Hospitals & Medical Services | 22.40% |
| Current Assets | 1.32% |
| Chemicals - Speciality | 0.98% |
| Medical Equipment & Accessories | 0.60% |
| Equity | 0.01% |
Stock Holdings
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| SUN PHARMACEUTICALS INDUSTRIES | 9.42% | ₹ 104.22 | Pharmaceuticals |
| AJANTA PHARMA LTD. | 7.04% | ₹ 77.94 | Pharmaceuticals |
| LUPIN LTD. | 5.79% | ₹ 64.04 | Pharmaceuticals |
| GLENMARK PHARMACEUTICALS LTD. | 4.25% | ₹ 47.01 | Pharmaceuticals |
| APOLLO HOSPITALS ENTERPRISE LT | 3.75% | ₹ 41.45 | Hospitals & Medical Services |
| GLAND PHARMA LTD. | 3.54% | ₹ 39.22 | Pharmaceuticals |
| DIVIS LABORATORIES LTD. | 3.52% | ₹ 38.92 | Pharmaceuticals |
| DR REDDYS LABORATORIES LTD. | 3.48% | ₹ 38.52 | Pharmaceuticals |
| ALKEM LABORATORIES LTD | 3.47% | ₹ 38.35 | Pharmaceuticals |
| FORTIS HEALTHCARE LTD. | 2.98% | ₹ 32.99 | Hospitals & Medical Services |
| MAX HEALTHCARE INSTITUTE LTD | 2.85% | ₹ 31.51 | Hospitals & Medical Services |
| COHANCE LIFESCIENCES LIMITED | 2.66% | ₹ 29.45 | Pharmaceuticals |
| AUROBINDO PHARMA LTD. | 2.66% | ₹ 29.45 | Pharmaceuticals |
| CAPLIN POINT LABORATORIES LTD | 2.23% | ₹ 24.65 | Pharmaceuticals |
| PROCTOR & GAMBLE HEALTH LTD | 2.21% | ₹ 24.50 | Pharmaceuticals |
| SUDEEP PHARMA LIMITED | 2.19% | ₹ 24.18 | Pharmaceuticals |
| IPCA LABORATORIES LTD. | 2.17% | ₹ 24.03 | Pharmaceuticals |
| VIYASH SCIENTIFIC LTD | 2.11% | ₹ 23.31 | Pharmaceuticals |
| SAI LIFE SCIENCES LTD | 2.07% | ₹ 22.92 | Pharmaceuticals |
| JUPITER LIFE LINE HOSPITALS LTD | 2.06% | ₹ 22.79 | Hospitals & Medical Services |
| GLOBAL HEALTH LTD. | 2.02% | ₹ 22.33 | Hospitals & Medical Services |
| ASTER DM HEALTHCARE LTD | 1.94% | ₹ 21.52 | Hospitals & Medical Services |
| ANTHEM BIOSCIENCES LTD | 1.91% | ₹ 21.17 | Pharmaceuticals |
| ERIS LIFESCIENCES LTD | 1.84% | ₹ 20.37 | Pharmaceuticals |
| CIPLA LTD. | 1.83% | ₹ 20.22 | Pharmaceuticals |
| NET CURRENT ASSETS | 1.79% | ₹ 19.77 | Others |
| PFIZER LIMITED | 1.77% | ₹ 19.54 | Pharmaceuticals |
| METROPOLIS HEALTHCARE LTD | 1.66% | ₹ 18.41 | Hospitals & Medical Services |
| MARKSANS PHARMA LTD. | 1.65% | ₹ 18.26 | Pharmaceuticals |
| KRISHNA INSTITUTE OF MEDI SCIE | 1.55% | ₹ 17.15 | Hospitals & Medical Services |
| DR LAL PATHLABS LTD. | 1.26% | ₹ 14 | Hospitals & Medical Services |
| WINDLAS BIOTEC LTD | 1.13% | ₹ 12.50 | Pharmaceuticals |
| VIJAYA DIAGNOSTIC CENTRE LTD | 1.09% | ₹ 12.05 | Hospitals & Medical Services |
| ACUTAAS CHEMICALS LIMITED | 1.07% | ₹ 11.87 | Pharmaceuticals |
| SANOFI CONSUMER HEALTHCARE INDIA LTD | 0.98% | ₹ 10.85 | Chemicals - Speciality |
| EMCURE PHARMACEUTICALS LTD | 0.94% | ₹ 10.45 | Pharmaceuticals |
| RAINBOW CHILDRENS MEDICARE LTD | 0.85% | ₹ 9.36 | Hospitals & Medical Services |
| AARTI PHARMALABS LTD | 0.84% | ₹ 9.27 | Pharmaceuticals |
| JUBILANT PHARMOVA LIMITED | 0.70% | ₹ 7.77 | Pharmaceuticals |
| BIOCON LTD. | 0.70% | ₹ 7.80 | Pharmaceuticals |
| SYNGENE INTERNATIONAL LTD. | 0.69% | ₹ 7.60 | Pharmaceuticals |
| ORCHID PHARMA LTD. | 0.56% | ₹ 6.20 | Pharmaceuticals |
| ALEMBIC PHARMACEUTICALS | 0.52% | ₹ 5.78 | Pharmaceuticals |
| LAXMI DENTAL LIMITED | 0.26% | ₹ 2.92 | Medical Equipment & Accessories |
| CLEARING CORPORATION OF INDIA LTD. STD - MARGIN | 0.01% | ₹ 0.09 | Others |
Returns
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | 5.96% | 14.25% | 17.69% | 27.64% |
| Category returns | 4.57% | 8.98% | 11.80% | 25.25% |
Fund Objective
An open-ended fund which exclusively invests in the equities of the Pharma & Healthcare sector companies. This fund is one of the growth sector funds aiming to invest in companies engaged in ... Read more
AMC Details
Name
UTI Asset Management Co. Ltd.
Date of Incorporation
01 Feb 2003
CEO
Mr. Vetri Subramaniam
CIO
Mr Vetri Subramaniam
Type
Bank Sponsored
Address
UTI Towers,
Gn Block,
Bandra Kurla Complex,
Bandra (East), Mumbai, Maharashtra, India - 400051
Website
https://www.utimf.com
Email
Top Funds from Equity - Sectoral/Thematic
Top Funds from UTI Asset Management Co. Ltd.
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
UTI Equity Savings Fund
Hybrid
Regular
|
₹18.80 | 4.28% | 32.17% | 55.27% | ₹788 | 1.65% |
Moderate
|
|
UTI Equity Savings Fund
Hybrid
Regular
|
₹18.80 | 4.28% | 32.17% | 55.27% | ₹788 | 1.65% |
Moderate
|
|
UTI Equity Savings Fund
Hybrid
Regular
|
₹18.80 | 4.28% | 32.17% | 55.27% | ₹788 | 1.65% |
Moderate
|
|
UTI Equity Savings Fund
Hybrid
Regular
|
₹18.80 | 4.28% | 32.17% | 55.27% | ₹788 | 1.65% |
Moderate
|
|
UTI Equity Savings Fund
Hybrid
Regular
|
₹18.80 | 4.28% | 32.17% | 55.27% | ₹788 | 1.65% |
Moderate
|
|
UTI Equity Savings Fund
Hybrid
Regular
|
₹18.80 | 4.28% | 32.17% | 55.27% | ₹788 | 1.65% |
Moderate
|
|
UTI Equity Savings Fund
Hybrid
Regular
|
₹18.80 | 4.28% | 32.17% | 55.27% | ₹788 | 1.65% |
Moderate
|
|
UTI BSE Sensex ETF
ETF
Regular
|
₹856.84 | -2.53% | 31.99% | 67.36% | ₹49,710 | 0.05% |
Very High
|
|
UTI Large Cap Fund - Direct Plan
Largecap
Direct
|
₹61.68 | -2.53% | 31.49% | 45.57% | ₹11,203 | 0.93% |
Very High
|
|
UTI Large Cap Fund - Direct Plan
Largecap
Direct
|
₹61.68 | -2.53% | 31.49% | 45.57% | ₹11,203 | 0.93% |
Very High
|
FAQs
What is the current NAV of UTI Healthcare Fund - Direct Plan Growth?
The current Net Asset Value (NAV) of UTI Healthcare Fund - Direct Plan Growth is ₹344.60 as of 07 May 2026. NAV represents the per-unit market value of the fund and is updated daily based on the closing prices of the underlying securities.
What is the fund size (AUM) of UTI Healthcare Fund - Direct Plan Growth?
The Assets Under Management (AUM) of UTI Healthcare Fund - Direct Plan Growth is ₹1,055.53 Crores. AUM indicates the total market value of assets managed by the fund and reflects investor confidence and fund popularity.
What are the historical returns of UTI Healthcare Fund - Direct Plan Growth?
UTI Healthcare Fund - Direct Plan Growth has delivered returns of 14.25% (1 Year), 27.64% (3 Year), 15.40% (5 Year). Past performance does not guarantee future results, and investors should consider their risk appetite before investing.
What is the risk level of UTI Healthcare Fund - Direct Plan Growth?
UTI Healthcare Fund - Direct Plan Growth has a risk rating of 'Very High' as per the SEBI Riskometer. This indicates the fund is suitable for very aggressive investors comfortable with significant market volatility. Investors should align their investment choices with their personal risk tolerance and financial goals.
What is the minimum investment amount for UTI Healthcare Fund - Direct Plan Growth?
The minimum lumpsum investment required for UTI Healthcare Fund - Direct Plan Growth is ₹5,000. The fund also offers SIP (Systematic Investment Plan) option starting from as low as ₹500, making it accessible for regular investments. This allows investors to start their mutual fund journey with a manageable amount.
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article
-
SIP നിക്ഷേപത്തിൽ ചരിത്രനേട്ടം; ഏപ്രിൽ മാസത്തെ മ്യൂച്വൽ ഫണ്ട് കണക്കുകൾ വിപണിയെ ഞെട്ടിക്കുമോ? -
റെക്കോർഡുകൾ തകർക്കുമോ? മ്യൂച്വൽ ഫണ്ട് നിക്ഷേപകർ ഉറ്റുനോക്കുന്ന AMFI ഏപ്രിൽ റിപ്പോർട്ട് വരുന്നു -
സെബിയുടെ പുതിയ മ്യൂച്വൽ ഫണ്ട് നിയമങ്ങൾ: നിങ്ങളുടെ എസ്ഐപി ലാഭം ഇനി കൂടുമോ? -
മ്യൂച്വൽ ഫണ്ട് നിക്ഷേപകർക്ക് ആശങ്കയോ? എക്സ്പെൻസ് റേഷ്യോയിലെ ഈ മാറ്റം നിങ്ങളുടെ പോക്കറ്റിനെ ബാധിക്കുമോ? -
മ്യൂച്വൽ ഫണ്ട് ആപ്പിലെ മാറ്റങ്ങൾ കണ്ട് പേടിക്കണോ? സെബിയുടെ പുതിയ നീക്കം നിങ്ങളുടെ പോക്കറ്റിനെ എങ്ങനെ ബാധിക്കും? -
മ്യൂച്വൽ ഫണ്ട് ആപ്പിലെ ചെലവ് വർധന കണ്ട് ഞെട്ടിയോ? പേടിക്കേണ്ട, ഇത് സെബിയുടെ പുതിയ തന്ത്രം! -
മ്യൂച്വൽ ഫണ്ട് നിക്ഷേപകർ അറിയണം, നിങ്ങളുടെ ലാഭം ചോരുന്നുണ്ടോ? -
മ്യൂച്വൽ ഫണ്ട് നിക്ഷേപകർക്ക് ഈ ആഴ്ച നിർണ്ണായകമായതെന്ത്? -
എസ്ഐപി നിക്ഷേപം കുതിക്കുന്നു; സാധാരണക്കാർക്ക് മുന്നിൽ പുതിയ വഴി -
എസ്ഐപി നിക്ഷേപം കുതിക്കുന്നു: നിക്ഷേപകർക്ക് വൻ നേട്ടമോ അതോ ചതിക്കുഴിയോ?
Top Mutual Fund House in India
Notifications
Settings
Clear Notifications
Notifications
Use the toggle to switch on notifications
-
Block for 8 hours
-
Block for 12 hours
-
Block for 24 hours
-
Don't block
Stay Informed.
Get news and videos anytime and anywhere.
Sign in with Google By signing in, you agree to our Terms and Privacy Policy
Gender
Select your Gender
- Male
- Female
- Others
Age
Select your Age Range
- Under 18
- 18 to 25
- 26 to 35
- 36 to 45
- 45 to 55
- 55+
X